If PAR can pass P3 (and it is a high probability of success), and can demonstrate DMOAD, for OA treatment, this is just one of many indications amongst many other indications it can pursue in the future. Hence, the sky will be the limit. DMOAD is important, and will take SP to where we will never thought possible.
Funding is now the only missing piece from the puzzle. Once sorted, everything will fall into place and I am holding on and won't sell. Look at PME and its SP trajectory - the runway for PAR is huuuuge!
PAR Price at posting:
61.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)